Hodgkin's Lymphoma

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Winning the Battle Against Lymphoma

There are many types and subtypes of lymphoma, each requiring a specialized treatment. Lymphoma patients who choose SCCA receive expertly targeted and delivered care, along with access to new therapies explored in clinical studies conducted at SCCA and its founding organizations, Fred Hutchinson Cancer Research Center and UW Medicine.

Statistics Are Abstract; Lives Aren’t

Susan Ault, Lymphoma Survivor Susan Ault moved to the Pacific Northwest to get treatment for her lymphoma at SCCA. Now a survivor, she’s taken up permanent residence in Sequim. Read more about Susan.

If you do have lymphoma, where you choose to go for initial treatment has a significant impact on your likelihood of survival. Lymphoma patients at SCCA have access to advanced therapies and treatments being explored in several dozen ongoing clinical trials for lymphoma conducted at Fred Hutchinson Cancer Research Center and UW Medicine. For people with lymphoma who are good candidates for stem cell transplants, the Fred Hutchinson Transplant program at SCCA is the most experienced transplant center in the world. As you can see below, patients treated for lymphoma at SCCA have high five-year survival rates.

Lymphoma Survival Rates

Below are the five-year survival rates for lymphoma patients treated by SCCA compared to patients who were treated for lymphoma elsewhere. This information was collected by the National Cancer Data Base (NCDB) for patients who were diagnosed and treated between 2003 and 2005 and then followed for five years. We're only showing survival rates for patients who were diagnosed with stage I and stage IV lymphoma. There were not enough patients who were first diagnosed and treated at SCCA with stage II or stage III lymphoma to provide meaningful results.

Stage I Lymphoma

  • SCCA patients are represented by the green line. Their five-year survival rate was 86 percent from the time they were first diagnosed by SCCA. Note that only patients who received all of their care from SCCA are included.
  • Patients from the other types of treatment centers—Community Cancer Centers, Comprehensive Community Cancer Centers, and Academic/Research Hospitals—are represented by the yellow line. Their five-year survival rate was 74 percent.

Stage IV Lymphoma

  • SCCA patients are represented by the green line. Their five-year survival rate was 79 percent from the time they were first diagnosed by SCCA. Note that only patients who received all of their care from SCCA are included.
  • Patients from the other types of treatment centers—Community Cancer Centers, Comprehensive Community Cancer Centers, and Academic/Research Hospitals—are represented by the yellow line. Their combined five-year survival rate was 50 percent.

The NCDB tracks the outcomes of 70 percent of all newly diagnosed cancer in the United States from more than 1,500 commission-accredited cancer programs. It has been collecting data from hospital cancer registries since 1989 and now has almost 29 million records. 

Frequently Asked Questions

Data Collection Methodology